Cardiac Wire #284 June 30, 2025
A Polymer Mitral Valve Success and More From NYV 2025
Cardiac Wire #283 June 26, 2025
Microplastics Impact CVD, J&J Injunction, and Novo Quits H&H
Cardiac Wire #282 June 23, 2025
Edwards’ Evoque ADEs, Philips’ Angio Recall, and Baby BP
Cardiac Wire #281 June 19, 2025
Lilly Buys Verve, Cold-Triggered AFib, and GLUCOSE
Cardiac Wire #280 June 16, 2025
Abelacimab’s Safety, CABG + Ablation, and UK TAVR Investigation
Cardiac Wire #279 June 12, 2025
BP Triple Polypill, Robot TAVR Explant, and Polymer MVs
Cardiac Wire #278 June 9, 2025
Decreasing PCI Contrast, ECG for AS, and HF is Expensive
Cardiac Wire #277 June 5, 2025
Regeneron Races to GLP-1s, Titanium Hearts, and Breastfeeding vs. ASCVD
Cardiac Wire #276 June 2, 2025
The ABYSS Answers, PPMI’s Risks, and RNAi for Lp(a)
Cardiac Wire #275 May 29, 2025
BSCI Quits TAVR, Major PE CV Acquisition, and Mayo + Corify
Cardiac Wire #274 May 22, 2025
Navitor vs. Sapien, Regeneron Wins Lawsuit, and Pricey GLP-1s
Cardiac Wire #273 May 19, 2025
Wegovy’s Rapid CV Impact, HF Iron Man, and BP Pills in Bed
Cardiac Wire #272 May 15, 2025
Tirzepatide Triumphs, Killer Foods, and MAPLE-HCM
Cardiac Wire #271 May 12, 2025
New ASCVD Biomarker, BATMAN Begins, and AI Predicts LBBB
Cardiac Wire #270 May 8, 2025
Obicetrapib’s Results Show, MAR001 Progresses, and Fibrosis Inhibition
Cardiac Wire #269 May 5, 2025
TAVR for Asymptomatic AS, PFA’s Risks, and CVS Adopts Wegovy
Cardiac Wire #268 May 1, 2025
HRS’ Top Six, X-rays for CVD, and OmniaSecure’s Approval
Cardiac Wire #267 April 28, 2025
GLP-1s Impact AFib, Kardium’s PFA Shines, and AccurKardia + HeartBeam
Cardiac Wire #266 April 24, 2025
